|Articles|June 29, 2023
DIA 2023: Giving Patients More Power in Decision Making
Advertisement
In an interview at the 2023 DIA annual meeting with ACT editor, Andy Studna, Jean Sposaro, program lead, TransCelerate BioPharma, and director, global drug development operations industry collaborations, Bristol Myers Squibb discusses initiatives that TransCelerate is currently working on to empower patients.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Selective Safety Data and Visit Reduction, Protocol Design Execution Gaps, and China Trial Security Investigation
2
ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch
3
Protocol Design Doesn't Fail in the Protocol, It Fails in Transition to Trial
4
The Data Behind Reducing Trial Burden Without Sacrificing Quality
5